THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

Objectives: To determine differences in overall survival and quality of life among patients with stage IV non-small cell lung cancer non-metastatic to the brain treated with

Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern

Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de

The objective of the present study was to analyze the effect of chemotherapy on the physical condition of patients with advanced non-small cell lung cancer

(2015) Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small- cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03..

The aim of this study was to evaluate the frequency of epidermal growth factor receptor and KRAS mutations in a population of Brazilian patients with non-small cell lung

CONCLUSION: Serum albumin levels appear to be a significant independent prognostic factor for tumor recurrence in patients with stage I non-small cell lung cancer who have